Listed

EDGEWELL PERSONAL CARE Co: Form 10-Q for the period ended Dec 31, 2021

Filed with the SEC on Feb 8, 2022 and accepted by EDGAR at Feb 8, 2022, 12:03 ET.

Share

Management's discussion and analysis

As filed, 31,970 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(in millions, except per share data, unaudited)

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited Condensed Consolidated Financial Statements and the accompanying notes included in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K filed with the SEC on November 19, 2021 (the “2021 Annual Report”). The following discussion may contain forward-looking statements that reflect our plans, estimates, and beliefs and involve risks, uncertainties, and assumptions. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences include those discussed within “Forward-Looking Statements” below and in Item 1A. Risk Factors and “Forward-Looking Statements” included within our 2021 Annual Report.

Forward-Looking Statements

This document contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”), as amended. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of Edgewell Personal Care Company (“Edgewell”, “we” or “our Company”) or any of our businesses. Forward-looking statements generally can be identified by the use of words or phrases such as “believe,” “expect,” “expectation,” “anticipate,” “may,” “could,” “intend,” “belief,” “estimate,” “plan,” “target,” “predict,” “likely,” “will,” “should,” “forecast,” “outlook,” or other similar words or phrases. These statements are not based on historical facts, but instead reflect our expectations, estimates, or projections concerning future results or events, including, without limitation, the future earnings and performance of our Company or any of our businesses, and the integration of the Billie acquisition and expected benefits from this transaction, including growth opportunities and cost savings. Many factors outside our control could affect the realization of these estimates. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause our actual results to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or projections will be achieved. The forward-looking statements included in this report are only made as of the date of this report and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances, except as required by law. You should not place undue reliance on these statements.

In addition, other risks and uncertainties not presently known to us or that we presently consider immaterial could significantly affect the forward-looking statements. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. Risks and uncertainties include those detailed from time to time in our publicly filed documents, including in Item 1A. Risk Factors of Part I of our 2021 Annual Report.

Non-GAAP Financial Measures

While we report financial results in accordance with GAAP, this discussion also includes non-GAAP measures. These non-GAAP measures are referred to as “adjusted” or “organic” and exclude items such as restructuring costs, acquisition and integration costs, and other non-standard items. Reconciliations of non-GAAP measures are included within this Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. We use this non-GAAP information internally to make operating decisions and believe it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. Given certain significant events, including the acquisition of Billie Inc. (“Billie”), we view the use of non-GAAP measures that take into account the impact of these unique events as particularly valuable in understanding our underlying operational results and providing insights into future performance. The information can also be used to perform trend analysis and to better identify operating trends that may otherwise be masked or distorted by the types of items that are excluded. This non-GAAP information is also a component in determining management’s incentive compensation. Finally, we believe this information provides more transparency.

The following provides additional detail on our non-GAAP measures:

  • We analyze net sales and segment profit on an organic basis to better measure the comparability of results between periods. Organic net sales and organic segment profit exclude the impact of changes in foreign currency and the impact of the Billie acquisition.
  • Organic net sales will be unfavorably impacted in fiscal 2022 by the Billie acquisition as sales that were previously reported as third party sales to Billie are now included as inter-company sales.
  • Segment profit will be unfavorably impacted in fiscal 2022 as a result of a change in the timing of profit recognition due to the Billie acquisition. Subsequent to the acquisition of Billie, profit previously earned on sales to Billie will be deferred until Billie sells to a third party.
  • Additionally, we utilize “adjusted” non-GAAP measures including gross profit, SG&A, operating income, income taxes, net earnings, and diluted earnings per share internally to make operating decisions. The following items are excluded when analyzing non-GAAP measures: restructuring and related costs, acquisition and integration costs, and other non-standard items.

All comparisons are with the same period in the prior year, unless otherwise noted.

Industry and Market Data

Unless we indicate otherwise, we base the information concerning our industry contained or incorporated by reference herein on our general knowledge of and expectations concerning the industry. Our market position, market share, and industry market size are based on our estimates using internal and external data from various industry analyses, our internal research and adjustments, and assumptions that we believe to be reasonable. We have not independently verified data from industry analyses and cannot guarantee its accuracy or completeness. In addition, we believe that data regarding the industry, market size and our market position and market share within such industry provide general guidance but are inherently imprecise and have not been verified by any independent source. Further, our estimates and assumptions involve risks and uncertainties and are subject to change based on various factors, including those discussed in Item 1A. Risk Factors in Part I of our 2021 Annual Report. These and other factors could cause results to differ materially from those expressed in the estimates and assumptions. You are cautioned not to place undue reliance on this data.

Retail sales for purposes of market size, market position and market share information are based on retail sales in U.S. dollars.

Trademarks and Trade Names

We own or have rights to use trademarks and trade names that we use in conjunction with the operation of our business, which appear throughout this Quarterly Report on Form 10-Q. We may also refer to brand names, trademarks, service marks and trade names of other companies and organizations, and these brand names, trademarks, service marks and trade names are the property of their respective owners.

Impact of COVID-19

Throughout the novel coronavirus 2019 (“COVID-19”) pandemic, we have taken and continue to take significant measures to protect our employees and business, while remaining in compliance with local guidelines and requirements.

The Company’s top priority during this time continues to be ensuring the health and welfare of our employees and additional measures have been put in place at all of our manufacturing locations. To date, we have not experienced any material operational disruptions across our manufacturing or distribution facilities.

The prolonged COVID-19 environment has resulted in increased supply chain challenges across labor management, product procurement and distribution. The continued duration and severity of COVID-19 may cause further disruptions related to our key suppliers, increase procurement costs and impact our ability to hire and retain employees, which may result in higher labor costs going forward. However, the impact, timing and severity of potential disruptions cannot be reasonably estimated at this time.

We expect to maintain adequate liquidity during these uncertain times and we will continue to assess the impact that COVID-19 has on our liquidity needs and current economic market conditions. As noted within “Liquidity and Capital Resources” below, COVID-19 has not had a significant impact on our liquidity, cash flows or capital resources.

Significant Events

Acquisitions

On November 29, 2021, the Company completed the acquisition of Billie, a leading U.S. based consumer brand company that offers a broad portfolio of personal care products for women for a purchase price of $308.8, net of cash acquired. We purchased Billie utilizing a combination of cash on hand and drawing on our U.S. revolving credit facility due 2025 (“Revolving Credit Facility”). As a result of the acquisition, Billie became a wholly owned subsidiary of the Company. Refer to Note 2 of Notes to Condensed Consolidated Financial Statements for further discussion on the Billie acquisition.

Executive Summary

The following is a summary of key results for the first quarter of fiscal 2022 compared to the first quarter of fiscal 2021. Net earnings and earnings per share (“EPS”) for the periods presented were impacted by restructuring and related costs, acquisition and integration costs, and other non-standard items, as described in the table below. The impact of these items on reported net earnings and EPS are provided as a reconciliation of net earnings and EPS to adjusted net earnings and adjusted diluted EPS, both of which are non-GAAP measures.

First Quarter of Fiscal 2022

  • Net sales in the first quarter of fiscal 2022 were $463.3, up 2.7% compared to the prior year quarter. Organic net sales increased 2.5% compared to the prior year quarter due to higher volumes and favorable price across all segments, including growth in North America from Sun Care, Grooming and Feminine Care and growth in International driven by Wet Shave and Sun Care.
  • Net earnings in the first quarter of fiscal 2022 were $11.2 compared to $17.7 in the prior year quarter. On an adjusted basis, net earnings for the first quarter of fiscal 2022 were $23.2 compared to $23.3 in the prior year quarter. Adjusted earnings were flat compared to the prior year quarter as higher net sales were offset by lower margins from higher materials, labor, and warehousing and distribution costs and higher advertising and promotional expense (“A&P”) in support of executing our category and brand strategies.
  • Net earnings per diluted share during the first quarter of fiscal 2022 were $0.20 compared to $0.32 in the prior year quarter. On an adjusted basis, net earnings per diluted share during the first quarter of fiscal 2022 was $0.42 compared to $0.43 in the prior year quarter.
Three Months Ended December 31, 2021 Gross Profit SG&A Operating Income EBIT(1) Income taxes Net Earnings Diluted EPS
GAAP — Reported $189.9 $96.9 $31.8 $16.2 $5.0 $11.2 $0.20
Restructuring and related costs — — 2.2 2.2 0.5 1.7 0.03
Acquisition and integration costs 0.3 5.7 6.0 6.0 0.3 5.7 0.11
Value-added tax settlement costs — 3.4 3.4 3.4 1.1 2.3 0.04
Sun Care reformulation costs 3.3 — 3.3 3.3 1.0 2.3 0.04
Total Adjusted Non-GAAP $193.5 $87.8 $46.7 $31.1 $7.9 $23.2 $0.42
GAAP as a percent of net sales 41.0% 20.9% 6.9% GAAP effective tax rate 30.9%
Adjusted as a percent of net sales 41.8% 19.0% 10.1% Adjusted effective tax rate 25.3%
Three Months Ended December 31, 2020 Gross Profit SG&A Operating Income EBIT(1) Income taxes Net Earnings Diluted EPS
GAAP — Reported $193.3 $93.1 $41.6 $25.2 $7.5 $17.7 $0.32
Restructuring and related costs 0.1 0.6 4.4 4.4 1.1 3.3 0.07
Acquisition and integration costs 1.3 1.7 3.0 3.0 0.7 2.3 0.04
Total Adjusted Non-GAAP $194.7 $90.8 $49.0 $32.6 $9.3 $23.3 $0.43
GAAP as a percent of net sales 42.9% 20.6% 9.2% GAAP effective tax rate 29.7%
Adjusted as a percent of net sales 43.2% 20.1% 10.9% Adjusted effective tax rate 28.4%

(1) EBIT is defined as Earnings before Income taxes.

Operating Results

The following table presents changes in net sales for the first quarter of fiscal 2022, as compared to the corresponding period in fiscal 2021, and provides a reconciliation of organic net sales to reported amounts.

Net Sales

Net Sales - Total Company Period Ended December 31, 2021 Q1 % Chg
Net sales - fiscal 2021 $451.1
Organic 11.3 2.5%
Impact of Billie acquisition, net 6.8 1.5%
Impact of currency (5.9) (1.3)%
Net sales - fiscal 2022 $463.3 2.7%

For the first quarter of fiscal 2022, net sales were $463.3, an increase of 2.7%, including a $6.8, or 1.5%, impact from the acquisition of Billie and a $5.9 or 1.3% negative impact from currency movements. Organic net sales increased 2.5%, reflecting higher volumes and higher pricing in both North America and International markets. Wet Ones organic net sales declined 41%, reflecting the impact of cycling prior year quarter COVID-19 related growth of over 110%.

For further discussion regarding net sales, including a summary of reported versus organic changes, see “Segment Results.”

Gross Profit

Gross profit was $189.9 during the first quarter of fiscal 2022, compared to $193.3 in the prior year quarter. Gross margin as a percent of net sales for the first quarter of fiscal 2022 was 41.0%. Adjusted gross margin percentage was 41.8%, a decline of 140-basis points compared to the prior year quarter, as 130-basis points of favorable pricing, promotional efficiency and mix was more than offset by a 220-basis point net impact from higher cost of goods and a 50-basis point impact related to the negative effect of currency translation and other items.

Selling, General and Administrative Expense

Selling, general and administrative expense (“SG&A”) was $96.9 in the first quarter of fiscal 2022, or 20.9% of net sales, compared to $93.1 in the prior year quarter, or 20.6% of net sales. Adjusted SG&A as a percent of net sales was 19.0%, a decline of 110-basis points as lower incentive and fringe benefit costs were only partly offset by higher compensation expense and the additional costs associated with the Billie acquisition, including increased amortization expense.

Advertising and Sales Promotion Expense

For the first quarter of fiscal 2022, A&P was $46.2, up $5.0 compared to the prior year quarter of $41.2. A&P as a percent of net sales was 10.0%, up from 9.1% in the prior year period. The increase in A&P was driven by increases in Sun and Skin Care and Wet Shave.

Research and Development Expense

Research and development expense (“R&D”) for the first quarter of fiscal 2022 was $12.8, compared to $13.7 in the prior year quarter. As a percent of net sales, R&D was 2.8% in the first quarter of fiscal 2022 compared to 3.0% in the prior year quarter.

Interest Expense Associated with Debt

Interest expense associated with debt for the first quarter of fiscal 2022 was $17.3, compared to $17.4 in the prior year quarter. The decline in interest expense was the result of lower interest rate on the 4.125% $500 Senior Notes due 2029 compared to the 4.7% $500 Senior Notes due 2022. This decline was partially offset by higher overall debt balance from the draw on the Revolving Credit Facility in the first quarter of fiscal 2022.

Other Income, Net

Other income, net was $1.7 in the first quarter of fiscal 2022, compared to income of $1.0 in the prior year quarter. The increase in income was driven by favorable pension activity and favorable foreign exchange gains compared to the prior year quarter.

Income Tax Provision

The effective tax rate for the first three months of fiscal 2022 was 30.9%, compared to 29.7% in the prior year period. On an adjusted basis, the effective tax rate was 25.3% and 28.4% for the first quarter of fiscal 2022 and fiscal 2021, respectively. The fiscal 2022 effective tax rate and adjusted effective tax rate reflects an increase in Internal Revenue Service Code Section 162(m) permanent adjustments partially offset by favorable stock compensation vests compared to fiscal 2021.

The following table presents a reconciliation of the adjusted effective tax rate, which is a non-GAAP measure:

Three Months Ended December 31, 2021 Reported Adjustments (1) Adjusted (Non-GAAP) Three Months Ended December 31, 2020 Reported Adjustments (1) Adjusted (Non-GAAP)
Earnings before income taxes $16.2 $14.9 $31.1 $25.2 $7.4 $32.6
Income tax provision 5.0 2.9 7.9 7.5 1.8 9.3
Net earnings $11.2 $12.0 $23.2 $17.7 $5.6 $23.3
Effective tax rate 30.9% 29.7%
Adjusted effective tax rate 25.3% 28.4%

(1) Includes adjustments for expenses management excludes when analyzing the operating performance of the Company. Refer to the GAAP to Non-GAAP reconciliation above for a detailed listing of adjustments.

Operating Model Redesign

In Fiscal 2022, we expect to take specific actions to strengthen our operating model, simplify our organization and improve manufacturing and supply chain efficiency and productivity. As a result of these actions, we expect to incur one-time charges of approximately $17 in fiscal 2022. We incurred $2.2 during the first quarter of fiscal 2022, primarily related to employee severance and benefit costs.

Segment Results

The following tables present changes in segment net sales and segment profit for the first quarter of fiscal 2022, compared to the corresponding period in fiscal 2021, and provide a reconciliation of organic segment net sales and organic segment profit to reported amounts. For a reconciliation of segment profit to Earnings before income taxes, refer to Note 15 of Notes to Condensed Consolidated Financial Statements.

Our operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and, in most cases, a combined sales force and management teams. We apply a fully allocated cost basis in which shared business functions are allocated between the segments.

We completed the acquisition of Billie on November 29, 2021. The net sales and segment profit activity related to Billie products were included in the Wet Shave segment for the post-acquisition period.

Wet Shave

Net Sales - Wet Shave Quarter Ended December 31, 2021 Q1 % Chg
Net sales - fiscal 2021 $279.1
Organic 6.0 2.1%
Impact of Billie acquisition, net 6.8 2.4%
Impact of currency (5.8) (2.0)%
Net sales - fiscal 2022 $286.1 2.5%

Wet Shave net sales for the first quarter of fiscal 2022 increased 2.5% compared to the prior year quarter, inclusive of a 2.4% increase from the acquisition of Billie and a 2.0% decline due to currency movements. Organic net sales increased $6.0, or 2.1%, driven by growth in Women’s shave and Disposables, partly offset by declines in Men’s Systems, primarily in North America, and Shave Preps, which were negatively impacted by supply chain issues and out of stocks.

Segment Profit - Wet Shave Quarter Ended December 31, 2021 Q1 % Chg
Segment profit - fiscal 2021 $52.6
Organic 3.2 6.1%
Impact of Billie acquisition, net (2.4) (4.6)%
Impact of currency (1.9) (3.6)%
Segment profit - fiscal 2022 $51.5 (2.1)%

Wet Shave segment profit for the first quarter of fiscal 2022 was $51.5, down $1.1, or 2.1%, compared to the prior year quarter, inclusive of the impact of currency movements. Organic segment profit increased $3.2, or 6.1%, as increased net sales and favorable gross margins were offset by higher A&P for Men’s systems during the quarter. Segment profit was negatively impacted $2.4 as a result of the Billie acquisition due to timing of profit recognition.

Sun and Skin Care

Sun and Skin Care segment net sales and profit are affected by the seasonality of sun care products. As a result, segment net sales and profit have historically been higher in the second and third quarters of the fiscal year.

Net Sales - Sun and Skin Care Quarter Ended December 31, 2021 Q1 % Chg
Net sales - fiscal 2021 $103.0
Organic 2.0 1.9%
Impact of currency (0.2) (0.2)%
Net sales - fiscal 2022 $104.8 1.7%

Sun and Skin Care net sales for the first quarter of fiscal 2022 increased 1.7% compared to the prior year quarter, inclusive of a 0.2% decline due to currency movements. Organic net sales increased $2.0, or 1.9%. The increase in organic net sales was primarily driven by Sun Care growth of more than 40%, reflecting market share gains and continued category recovery in both U.S. and international markets. Additionally, Grooming grew 7%, primarily in North America. Wet Ones organic net sales declined 41%, reflecting the impact of cycling prior year quarter COVID-19 related growth of over 110%.

Segment Profit - Sun and Skin Care Quarter Ended December 31, 2021 Q1 % Chg
Segment profit - fiscal 2021 $5.2
Organic (1.3) (25.0)%
Impact of currency (0.2) (3.8)%
Segment profit -fiscal 2022 $3.7 (28.8)%

Segment profit for the first quarter of fiscal 2022 was $3.7, a decrease of $1.5, compared to the prior year quarter. Organic segment profit decreased $1.3, as higher sales were more than offset by inflationary cost pressures and higher A&P spend.

Feminine Care

Net Sales - Feminine Care Quarter Ended December 31, 2021 Q1 % Chg
Net sales - fiscal 2021 $69.0
Organic 3.3 4.8%
Impact of currency 0.1 0.1%
Net sales - fiscal 2022 $72.4 4.9%

Feminine Care net sales for the first quarter of fiscal 2022 increased $3.4, or 4.9%. The increase in net sales was driven by favorable pricing and increased volumes, primarily in North America.

Segment Profit - Feminine Care Quarter Ended December 31, 2021 Q1 %Chg
Segment profit -fiscal 2021 $8.8
Organic (0.5) (5.6)%
Impact of currency 0.1 1.1%
Segment profit - fiscal 2022 $8.4 (4.5)%

Feminine Care segment profit for the first quarter of fiscal 2022 was $8.4, a decrease of $0.4, or 4.5%, compared to the prior year quarter. The decline was driven by lower gross margin, partly offset by lower A&P and SG&A.

General Corporate and Other Expenses

Quarter Ended December 31, 2021 2020
Corporate expenses $10.8 $12.1
Restructuring and related costs 2.2 4.4
Acquisition and integration costs 6.0 3.0
Value-added tax settlement costs 3.4 —
Sun Care reformulation costs 3.3 —
General corporate and other expenses $25.7 $19.5
% of net sales 5.5% 4.3%

For the first quarter of fiscal 2022, general corporate expenses were $10.8, or 2.3% of net sales, compared to $12.1, or 2.7% of net sales, in the prior year quarter. For the first quarter of fiscal 2022, the decline in corporate expense was primarily due to lower incentive and fringe benefit costs.

Liquidity and Capital Resources

To date, COVID-19 has not had a significant impact on our liquidity or capital resources. However, the COVID-19 pandemic has led to disruption and volatility in the global capital markets, which, depending on future developments, could impact our capital resources and liquidity in the future.

At December 31, 2021, a portion of our cash balances were located outside the U.S. Given our extensive international operations, a significant portion of our cash is denominated in foreign currencies. We manage our worldwide cash requirements by reviewing available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. We generally repatriate a portion of current year earnings from select non-U.S. subsidiaries only if the economic cost of the repatriation is not considered material.

The counterparties that hold our deposits consist of major financial institutions. We consistently monitor positions with, and the credit ratings of, counterparties both internally and by using outside ratings agencies.

Our total borrowings were $1,475.4 at December 31, 2021, including $225.4 tied to variable interest rates. Our total borrowings at September 30, 2021 were $1,276.5. We drew down $198.0 on the Revolving Credit Facility primarily to fund the acquisition of Billie during the three months ended December 31, 2021. Taking into account outstanding letters of credit of $6.3, as of December 31, 2021, $220.7 was available under the Revolving Credit Facility. We had outstanding international borrowings, recorded in Notes payable, of $27.4 and $26.5 as of December 31, 2021 and September 30, 2021, respectively.

Effective February 7, 2022, we increased the maximum receivables sold facility amount under the Sixth Amendment to Master Accounts Receivable Purchase Agreement to $180.0 from $150.0 and amended the pricing index used to determine the purchase price for subject receivables from LIBOR to the Bloomberg Short Term Bank Yield Index (“BSBY”). The applicable margin that is added to the BSBY pricing index specific for each obligor was unchanged. Except as noted above, all other terms, conditions, obligations, covenants or agreements contained in the Accounts Receivable Facility are unmodified in all respects and continue in full force and effect.

Historically, we have generated, and expect to continue to generate, positive cash flows from operations. Our cash flows are affected by the seasonality of our Sun Care products, typically resulting in higher net sales and increased cash generated in the second and third quarter of each fiscal year. While we cannot reasonably estimate the full impact COVID-19 will have on our cash flows, we believe our cash on hand, cash flows from operations and borrowing capacity under our Revolving Credit Facility will be sufficient to satisfy our future working capital requirements, interest payments, R&D activities, capital expenditures, and other financing requirements for at least the next 12 months. We will continue to monitor our cash flows, spending and liquidity needs.

Short-term financing needs consist primarily of working capital requirements and principal and interest payments on our long-term debt. Long-term financing needs will depend largely on potential growth opportunities, including acquisition activity and repayment or refinancing of our long-term debt obligations. We may, from time-to-time, seek to repurchase shares of our common stock. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. Our long-term liquidity may be influenced by our ability to borrow additional funds, renegotiate existing debt, and raise equity on terms that are favorable to us.

As of December 31, 2021, we were in compliance with the provisions and covenants associated with our debt agreements.

Cash Flows

A summary of our cash flow activities is provided in the following table:

Net cash (used by) from: Three Months Ended December 31, 2021 2020
Operating activities $(79.0) $(82.5)
Investing activities (312.7) (2.3)
Financing activities 155.5 (5.5)
Effect of exchange rate changes on cash (3.2) 6.4
Net decrease in cash and cash equivalents $(239.4) $(83.9)

Operating Activities

Cash flow used by operating activities was $79.0 during the first quarter of fiscal 2022, compared to cash flows used by operating activities of $82.5 during the prior year period. The decline in cash used by operations was primarily related to favorable changes in working capital.

Investing Activities

Cash flow used by investing activities was $312.7 during the first quarter of fiscal 2022, compared to cash used of $2.3 during prior year quarter. We completed the acquisition of Billie for $308.8, net of cash acquired, in the first quarter of fiscal 2022. Additionally, we collected $5.0 of proceeds from the sale of the Infant and Pet Care business during the first quarter of fiscal 2021, compared to $7.5 in the prior year period. Capital expenditures were $9.4 during the first quarter of fiscal 2022 compared to $10.2 in the prior year period.

Financing Activities

Net cash from financing activities was $155.5 during the first quarter of fiscal 2022, compared to cash used of $5.5 in the prior year period. We drew $198.0 on our Revolving Credit Facility primarily to fund the acquisition of Billie during the first quarter of fiscal 2022. We repurchased $24.5 of our common stock under our 2018 Board authorization to repurchase our common stock (the “Repurchase Plan”) compared to $9.2 in the prior year period. Dividend payments totaled $8.5 in the first quarter of fiscal 2022. We had financing outflows for employee equity awards held for taxes totaling $9.7 in the first quarter of fiscal 2022 compared to $3.0 in the prior year period.

Share Repurchases

During the first quarter of fiscal 2022, we repurchased 0.5 shares of our common stock for $24.5. We have 9.2 shares remaining under the Repurchase Plan. Future share repurchases, if any, would be made in the open market, privately negotiated transactions or otherwise, in such amounts and at such times as we deem appropriate based upon prevailing market conditions, business needs and other factors.

Dividends

On November 4, 2021, the Board declared a cash dividend of $0.15 per share of common stock outstanding. The dividend was paid on January 6, 2022 to holders of record as of the close of business on December 3, 2021.

Dividends declared during the three months ended December 31, 2021 totaled $8.4. Payments made for dividends during the three months ended December 31, 2021 totaled $8.5.

On February 4, 2022, the Board declared a quarterly cash dividend of $0.15 per common share for the first fiscal quarter. The dividend is payable April 5, 2022 to stockholders of record as of the close of business on March 8, 2022.

Commitments and Contingencies

Contractual Obligations

During the three months ended December 31, 2021, we drew $198.0 on the Revolving Credit Facility. As of December 31, 2021, future minimum repayments of debt were: $198.0 in fiscal 2025, $750.0 in fiscal 2028 and $500.0 in fiscal 2029.

There have been no other material changes in our contractual obligations since the presentation in our 2021 Annual Report.

Market risk

As filed, 1,238 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The market risk inherent in our financial instruments and positions represents the potential loss arising from adverse changes in currency rates, commodity prices, and interest rates. At times, we enter into contractual arrangements (derivatives) to reduce these exposures. For further information on our foreign currency derivative instruments, refer to Note 14 of Notes to Condensed Consolidated Financial Statements. As of December 31, 2021, there were no open derivative or hedging instruments for future purchases of raw materials or commodities. Our exposure to interest rate risk relates primarily to our variable-rate debt instruments, which currently bear interest based on LIBOR plus margin. As of December 31, 2021, our outstanding variable-rate debt included $225.4 related to our Revolving Credit Facility and international, variable-rate notes payable. Assuming a one-percent increase in the applicable interest rates, annual interest expense on these variable-rate debt instruments would increase approximately $2.0.

There have been no material changes in our assessment of market risk sensitivity since our presentation of Quantitative and Qualitative Disclosures About Market Risk in our 2021 Annual Report on Form 10-K.

Controls and procedures

As filed, 1,151 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Exchange Act, is recorded, processed, summarized and reported within the specified time periods, and that such information is accumulated and communicated to management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding required disclosure.

Our management, with the participation of our CEO and CFO, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2021. Based on that evaluation, our CEO and CFO concluded that, as of that date, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended December 31, 2021 that have materially affected, or are likely to materially affect, our internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-10-01 to 2021-12-31$463.3mus-gaap:Revenues
Cost of revenue3 months2021-10-01 to 2021-12-31$273.4mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2021-10-01 to 2021-12-31$189.9mus-gaap:GrossProfit
Research and development3 months2021-10-01 to 2021-12-31$12.8mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2021-10-01 to 2021-12-31$96.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2021-10-01 to 2021-12-31$31.8mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-10-01 to 2021-12-31$17.3mus-gaap:InterestExpense
Income tax3 months2021-10-01 to 2021-12-31$5.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-10-01 to 2021-12-31$11.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-10-01 to 2021-12-31$0.20us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-10-01 to 2021-12-31$0.21us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-10-01 to 2021-12-3155,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2021-10-01 to 2021-12-31−$79.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2021-10-01 to 2021-12-31$9.4mus-gaap:PaymentsToAcquireProductiveAssets
Dividends paid3 months2021-10-01 to 2021-12-31$8.5mus-gaap:PaymentsOfDividends
Share repurchases3 months2021-10-01 to 2021-12-31$24.5mus-gaap:PaymentsForRepurchaseOfCommonStock
Current assetsAt period end2021-12-31$966.9mus-gaap:AssetsCurrent
Total assetsAt period end2021-12-31$3.81bnus-gaap:Assets
Current liabilitiesAt period end2021-12-31$483.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-12-31$2.25bnus-gaap:Liabilities
Long-term debtAt period end2021-12-31$1.43bnus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2021-12-31$1.55bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001096752-22-000008. Last ingested by Listed: Nov 14, 2026, 23:53 ET. Listed shows no prices and gives no investment advice.